Importance Omalizumab is indicated for the management of chronic idiopathic urticaria
(CIU)(also known as chronic spontaneous urticaria) in adolescents and adults with …

The aim of this guidance is to provide recommendations to clinicians and other interested
parties on chronic urticaria in children. The Italian Society for Pediatrics (SIP), the Italian …

Background Omalizumab is an effective and well‐tolerated treatment for chronic
spontaneous urticaria (CSU). Markers and predictors of response are largely unknown, but …

Introduction: Chronic idiopathic/spontaneous urticaria (CIU/CSU) is a dermatological
condition characterized by itchy wheals and/or angioedema of continuous or intermittent …

Omalizumab is very effective in the majority of patients with severe chronic spontaneous
urticaria (CSU), but its mechanism of action is still unclear. In CSU the coagulation cascade …

Allergic diseases are of great concern because of their high prevalence, which is still rising
in several regions, their impact on patients' physical and psychological health, the huge …

Omalizumab is recombinant humanized monoclonal antibody to immunoglobulin E.
Guidelines for the treatment of chronic idiopathic urticaria (also known as chronic …

Abstract Purpose of Review Since omalizumab has been approved for urticaria, numerous
randomized and real-life observational trials have been published. We reviewed the period …

Background Clinical trials have shown the efficacy of omalizumabs efficacy in refractory
chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU), but real‐life …

Quite a few patients with chronic spontaneous urticaria (CSU) are refractory to H 1-
antihistamines, even though the dose of H 1-antihistamines is increased up to 4-fold. CSU …